Long-lasting cellular immunity to SARS-CoV-2 following infection or vaccination and implications for booster strategies
Alessio Mazzoni, Anna Vanni, Michele Spinicci, Giulia Lamacchia, Seble Tekle Kiros, Arianna Rocca, Manuela Capone, Nicoletta Di Lauria, Lorenzo Salvati, Alberto Carnasciali, Elisabetta Mantengoli, Parham Farahvachi, Lorenzo Zammarchi, Filippo Lagi, Maria Grazia Colao, Francesco Liotta, Lorenzo Cosmi, Laura Maggi, Alessandro Bartoloni, Gian Maria Rossolini, Francesco Annunziato
doi: https://doi.org/10.1101/2021.12.29.21268469
Alessio Mazzoni
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Anna Vanni
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Michele Spinicci
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy
Giulia Lamacchia
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Seble Tekle Kiros
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy
Arianna Rocca
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Manuela Capone
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Nicoletta Di Lauria
2Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy
Lorenzo Salvati
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Alberto Carnasciali
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Elisabetta Mantengoli
2Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy
Parham Farahvachi
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Lorenzo Zammarchi
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy
Filippo Lagi
2Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy
Maria Grazia Colao
3Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy
Francesco Liotta
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
4Immunology and Cell Therapy Unit, Careggi University Hospital, Florence, Italy
5Flow cytometry diagnostic center and immunotherapy, Careggi University Hospital, Florence, Italy
Lorenzo Cosmi
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
4Immunology and Cell Therapy Unit, Careggi University Hospital, Florence, Italy
Laura Maggi
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Alessandro Bartoloni
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
2Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy
Gian Maria Rossolini
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
3Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy
Francesco Annunziato
1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
5Flow cytometry diagnostic center and immunotherapy, Careggi University Hospital, Florence, Italy
Posted December 31, 2021.
Long-lasting cellular immunity to SARS-CoV-2 following infection or vaccination and implications for booster strategies
Alessio Mazzoni, Anna Vanni, Michele Spinicci, Giulia Lamacchia, Seble Tekle Kiros, Arianna Rocca, Manuela Capone, Nicoletta Di Lauria, Lorenzo Salvati, Alberto Carnasciali, Elisabetta Mantengoli, Parham Farahvachi, Lorenzo Zammarchi, Filippo Lagi, Maria Grazia Colao, Francesco Liotta, Lorenzo Cosmi, Laura Maggi, Alessandro Bartoloni, Gian Maria Rossolini, Francesco Annunziato
medRxiv 2021.12.29.21268469; doi: https://doi.org/10.1101/2021.12.29.21268469
Long-lasting cellular immunity to SARS-CoV-2 following infection or vaccination and implications for booster strategies
Alessio Mazzoni, Anna Vanni, Michele Spinicci, Giulia Lamacchia, Seble Tekle Kiros, Arianna Rocca, Manuela Capone, Nicoletta Di Lauria, Lorenzo Salvati, Alberto Carnasciali, Elisabetta Mantengoli, Parham Farahvachi, Lorenzo Zammarchi, Filippo Lagi, Maria Grazia Colao, Francesco Liotta, Lorenzo Cosmi, Laura Maggi, Alessandro Bartoloni, Gian Maria Rossolini, Francesco Annunziato
medRxiv 2021.12.29.21268469; doi: https://doi.org/10.1101/2021.12.29.21268469
Subject Area
Subject Areas
- Addiction Medicine (319)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2328)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11672)
- Forensic Medicine (10)
- Gastroenterology (690)
- Genetic and Genomic Medicine (3666)
- Geriatric Medicine (344)
- Health Economics (629)
- Health Informatics (2350)
- Health Policy (923)
- Hematology (338)
- HIV/AIDS (767)
- Medical Education (363)
- Medical Ethics (103)
- Nephrology (395)
- Neurology (3421)
- Nursing (193)
- Nutrition (515)
- Oncology (1792)
- Ophthalmology (530)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (228)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1018)
- Primary Care Research (413)
- Public and Global Health (6067)
- Radiology and Imaging (1247)
- Respiratory Medicine (818)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (394)
- Toxicology (50)
- Transplantation (171)
- Urology (144)